Trial intelligence / Profile preview

Dexmedetomidine effects on intraoperative neuroelectrophysiological monitoring during spinal surgery

ChiCTR1800016716Phase 4Recruiting

Sponsor
The 2nd Affiliated Hospital of Harbin Medical University
Start
Jul 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of dexmedetomidine (3 arms), sponsored by The 2nd Affiliated Hospital of Harbin Medical University. Primary endpoints: Somatosensory evoked potential and Motor evoked potential. Started Jul 2018; status: recruiting.

02

Drugs

dexmedetomidine

Beyond the preview

Go deeper on ChiCTR1800016716.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800016716.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call